VP

Veshali Porwal

Active Director Director DIN 06585104
DIN 06585104 First appointment May 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2013
Shareholding value •••• Premium profile

About Veshali Porwal

Data last updated:

Veshali Porwal is a Director at Dermakare Pharmaceuticals Private Limited (since 2013). The company operates in Pharma. Dermakare Pharmaceuticals Private Limited reported revenue of ₹12.35 Cr (FY 2024).

DIN 06585104
Primary Designation Director
Industry Pharma
First Appointment 01 May 2013
Oldest Company Age 15 yrs
Largest company Dermakare Pharmaceuticals Private Limited · ₹12.35 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 May 20132011₹12.35 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Dermakare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Veshali Porwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veshali Porwal

Veshali Porwal currently holds 1 directorship: Dermakare Pharmaceuticals Private Limited (Director, since 01 May 2013, revenue ₹12.35 Cr (FY 2024)).

Veshali Porwal was first appointed on 01 May 2013 as Director at Dermakare Pharmaceuticals Private Limited.

The current boards of Veshali Porwal's companies include Archana (Dermakare Pharmaceuticals Private Limited), Madhuri Mishra (Dermakare Pharmaceuticals Private Limited), Roop Chand Rastogi (Dermakare Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available